doi: 10.1007/BF01964035.
Effect of dihydroergocristine infusion on tolbutamide-induced insulin secretion in man
- PMID: 115708
- DOI: 10.1007/BF01964035
Item in Clipboard
Effect of dihydroergocristine infusion on tolbutamide-induced insulin secretion in man
Experientia.
.
Abstract
The insulinemic response to 1 g of tolbutamide i.v. is greatly enhanced (+ 145%) after a 60-min infusion of the alpha-lytic dihydrogenated ergot alkaloid, dihydroergocristine (83.3 micrograms/min, corresponding to a total dose of 5 mg) in 7 healthy subjects. No differences are observed in the glycemic responses.
Similar articles
-
[Potentiation of human insulin secretion due to tolbutamide after treatment with dihydroergocristine (DHC)].Boll Soc Ital Biol Sper. 1977 Nov 15;53(21):1834-8. Boll Soc Ital Biol Sper. 1977. PMID: 414769 Italian. No abstract available.
-
The regulation of glucose-induced insulin secretion by pre-stimulus glucose level and tolbutamide in normal man.Diabetologia. 1981 Sep;21(3):198-205. doi: 10.1007/BF00252654. Diabetologia. 1981. PMID: 7028551
-
Pharmacological interaction between tolbutamide and acetylsalicylic acid: study on insulin secretion in man.Int J Clin Pharmacol Ther Toxicol. 1990 Jun;28(6):229-34. Int J Clin Pharmacol Ther Toxicol. 1990. PMID: 2198232
-
[Cerebral actions of dihydroergocristine].Arzneimittelforschung. 1992 Nov;42(11A):1391-4. Arzneimittelforschung. 1992. PMID: 1492858 Review. German.
-
The kinetics of insulin in man. I. General aspects.Diabetes Metab Rev. 1987 Apr;3(2):335-63. doi: 10.1002/dmr.5610030201. Diabetes Metab Rev. 1987. PMID: 3552526 Review. No abstract available.